Cardiovascular Gene Therapy

One-Year Results from Vessel Growth Factor Trial are Encouraging

Published in Gene Therapy Weekly, December 7th, 2000

In one of the largest follow-up studies to date, researchers have shown that gene therapy for heart disease may relieve chest pain and does not increase the risk for cancer.

The results were reported November 12, 2000, at the American Heart Association's Scientific Sessions 2000, held in New Orleans, Louisiana.

Since gene therapy is used to stimulate the growth of new blood vessels, there has been concern that therapy may lead to overgrowth of other cells in the body, increasing the risk for cancer or other problems. Among 102 patients in the study, there were no significant differences in deaths, heart attacks, or cancer over the course of one...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2000-12-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry